| AK | Actinic keratosis |
| ASO | Antisense oligonucleotide |
| BCC | Basal cell carcinoma |
| CBM | Cutaneous biodistribution method |
| CLSM | Confocal laser scanning microscopy |
| Cy5 | Cyanine 5 |
| DAPI | 4′,6-diamidino-2-phénylindole |
| DEJ | Dermo-epithelial junction |
| DNA | Deoxyribonucleic acid |
| eGFP | Enhanced green fluorescent protein |
| EMA | European medical agency |
| Er: YAG | Solid state erbium-doped yttrium aluminium garnet |
| FDA | Food and Drug Administration |
| FM | Fluorescent microscopy |
| H&E | Hematoxylin and eosin |
| HPLC | High-pressure liquid chromatography |
| ID | Intradermal |
| INF-α | Interferon-α |
| IVT | In vitro transcribed |
| mIgG | Mouse immunoglobulin G |
| mRNA | Messenger ribonucleic acid |
| NGS | Normal goat serum |
| PBS | Phosphate buffer saline |
| PBST | Phosphate buffer saline with Tween 20 |
| PD | Papillary dermis |
| PSU | Pilosebaceous unit |
| RD | Reticular dermis |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| SCC | Squamous cell carcinoma |
| SC | Stratum corneum |
| SD | Sweat duct |
| siRNA | Small interfering ribonucleic acid |
| VE | Viable epidermis |
| VEGF-A | Vascular endothelial growth factor-A |